Evidence map›Paper›PMID 38363108›Full record

ArticleMicrobiology spectrum2024

Development of a rapid detection method for the macrolide resistance gene in

Takayuki Inagaki, Shoki Asahi, Kenji Ogawa, Taku Nakagawa, Teruko Ohkura, Yukari Osada, Toshiaki Nikai, Kiyofumi Yamada, Tetsuya Yagi, Kei-Ichi Uchiya

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Takayuki InagakiDivision of Pharmaceutical Sciences I, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan.ORCID 0009-0000-9147-556X
Shoki AsahiDepartment of Hospital Pharmacy, Japan Organization of Occupational Health and Safety, Chubu Rosai Hospital, Nagoya, Aichi, Japan.
Kenji OgawaDepartment of Respiratory Medicine, National Hospital Organization, Higashinagoya National Hospital, Nagoya, Aichi, Japan.
Taku NakagawaDepartment of Respiratory Medicine, National Hospital Organization, Higashinagoya National Hospital, Nagoya, Aichi, Japan.
Teruko OhkuraDepartment of Medical Technique, Nagoya University Hospital, Nagoya, Aichi, Japan.
Yukari OsadaDepartment of Medical Technique, Nagoya University Hospital, Nagoya, Aichi, Japan.
Toshiaki NikaiDepartment of Microbiology, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan.
Kiyofumi YamadaDepartment of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Tetsuya YagiDepartment of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Kei-Ichi UchiyaDepartment of Microbiology, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan.ORCID 0000-0001-9337-6354
Nagoya University Hospital · JPHigashi Nagoya National Hospital · JPMeijo University · JPChubu Rosai Hospital · JPNagoya University · JP

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 19K16444MEXT | Japan Society for the Promotion of Science (JSPS) 23K07930
6 · The paper itself

Abstract

Macrolide antibiotics such as clarithromycin (CLR) and azithromycin are the key drugs used in multidrug therapy for

Indexed as

Anti-Bacterial AgentsLung DiseasesMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesAzithromycinClarithromycinDrug Resistance, BacterialDrug Therapy, CombinationHumansLeprostatic AgentsMacrolidesMicrobial Sensitivity TestsMutationMycobacterium aviumMycobacterium avium ComplexAnti-Bacterial AgentsAzithromycinClarithromycinLeprostatic AgentsMacrolides23S rRNAamplification refractory mutation systemclarithromycindrug-resistance geneloop-mediated isothermal amplificationMycobacterium avium

Identifiers

PMID38363108
PMCPMC10986505
OpenAlexW4391884359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.